HEPION PHARMACEUTICALS, INC. Operating Lease, Weighted Average Discount Rate, Percent
HEPION PHARMACEUTICALS, INC. (HEPA) had Operating Lease, Weighted Average Discount Rate, Percent of 14.90% as of 2023-09-30, per its 10-Q filed 2023-11-20.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2025-04-08
- 2023-09-30: Operating Lease, Weighted Average Discount Rate, Percent 14.90%.
- 2023-08-31: Operating Lease, Weighted Average Discount Rate, Percent 14.90%; Operating Lease, Weighted Average Discount Rate, Percent as first filed 6.50%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.50%.
- 2022-09-30: Operating Lease, Weighted Average Discount Rate, Percent 6.50%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent | Operating Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2023-09-30 | 14.90% 10-Q · filed 2023-11-20 | |
| 2023-08-31 | 14.90% 10-K · filed 2025-04-08 | 6.50% 10-K · filed 2024-04-16 |
| 2022-12-31 | 6.50% 10-K · filed 2023-04-10 | |
| 2022-09-30 | 6.50% 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 6.50% 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 6.50% 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 6.50% 10-K · filed 2022-04-08 | |
| 2021-09-30 | 6.50% 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 6.50% 10-Q · filed 2021-08-16 | |
| 2021-03-31 | 6.50% 10-Q · filed 2021-05-14 | |
| 2020-12-31 | 6.50% 10-K · filed 2021-03-31 | |
| 2020-09-30 | 6.50% 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 6.50% 10-Q · filed 2020-08-12 | |
| 2020-03-31 | 6.50% 10-Q · filed 2020-06-29 | |
| 2019-12-31 | 6.50% 10-K · filed 2020-05-14 | |
| 2019-09-30 | 6.50% 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 6.50% 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 6.50% 10-Q · filed 2019-05-15 | |
| 2017-07-31 | 6.50% 10-K · filed 2025-04-08 | |
| 2014-07-31 | 14.90% 10-Q · filed 2024-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |